ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,064.20
0.91%
Dow Jones
38,225.66
0.85%
US Dollar vs MXN
16.93754
-0.20%
Brent Oil
83.835
0.25%
Bitcoin
59,043.78
-0.13%
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Harmony Biosciences Holdings Inc (HRMY)

  7. Harmony Biosciences Holdings Inc (HRMY) Noticias

HRMY Harmony Biosciences Holdings Inc

31.69
0.00 (0.00%)
Pre Mercado
Última actualización: 06:00:00
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Harmony Biosciences Holdings Inc HRMY NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
0.00 0.00% 31.69 06:00:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
31.69
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
30/4/202406:05GLOBEHarmony Biosciences Reports Strong First Quarter Financial..
30/4/202406:00PRNUSHarmony Biosciences Acquires Epygenix Therapeutics, Inc.,..
16/4/202407:05PRNUSHARMONY BIOSCIENCES TO REPORT FIRST QUARTER 2024 FINANCIAL..
11/4/202407:05PRNUSHARMONY BIOSCIENCES ANNOUNCES EXCLUSIVE AGREEMENT TO DEVELOP..
03/4/202407:05PRNUSHARMONY BIOSCIENCES INITIATES GLOBAL PHASE 3 REGISTRATIONAL..
26/3/202407:05PRNUSHARMONY BIOSCIENCES TO PARTICIPATE IN 23RD ANNUAL NEEDHAM..
11/3/202416:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202415:21EDGAR2Form 144 - Report of proposed sale of securities
28/2/202416:16EDGAR2Form 10-K/A - Annual report [Section 13 and 15(d), not S-K..
28/2/202407:05PRNUSHARMONY BIOSCIENCES TO PARTICIPATE IN UPCOMING INVESTOR..
22/2/202415:14EDGAR2Form S-8 - Securities to be offered to employees in employee..
22/2/202407:00EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
22/2/202406:45EDGAR2Form 8-K - Current report
22/2/202406:30GLOBEHarmony Biosciences Reports Fourth Quarter and Full Year..
21/2/202407:05PRNUSU.S. FOOD AND DRUG ADMINISTRATION GRANTS PRIORITY REVIEW TO..
20/2/202407:05PRNUSHARMONY BIOSCIENCES RECEIVES U.S. FOOD AND DRUG..
13/2/202418:06EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
08/2/202407:05PRNUSHARMONY BIOSCIENCES TO REPORT FOURTH QUARTER AND FULL YEAR..
26/1/202415:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/1/202415:58EDGAR2Form 3 - Initial statement of beneficial ownership of..
26/1/202415:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/1/202415:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/1/202407:30EDGAR2Form 8-K - Current report
08/1/202407:05PRNUSHARMONY BIOSCIENCES PRELIMINARY UNAUDITED FOURTH QUARTER AND..
03/1/202407:05PRNUSHARMONY BIOSCIENCES TO PRESENT AT THE 42ND ANNUAL J.P...
07/12/202315:06EDGAR2Form 8-K/A - Current report: [Amend]
07/12/202307:05PRNUSHARMONY BIOSCIENCES ANNOUNCES POSITIVE TOPLINE DATA FROM..
05/12/202307:05PRNUSHARMONY BIOSCIENCES TO PRESENT RESULTS FROM BEHAVIORAL STUDY..
16/11/202307:05PRNUSHARMONY BIOSCIENCES TO PARTICIPATE IN PIPER SANDLER 35th..
15/11/202307:05PRNUSHARMONY BIOSCIENCES RANKED AMONG TOP 25 FASTEST-GROWING..
08/11/202315:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/11/202308:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/11/202307:59EDGAR2Form 3 - Initial statement of beneficial ownership of..
08/11/202307:30EDGAR2Form 8-K - Current report
08/11/202307:05PRNUSHARMONY BIOSCIENCES APPOINTS PETER ANASTASIOU TO ITS BOARD..
31/10/202307:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
31/10/202306:45EDGAR2Form 8-K - Current report
31/10/202306:30GLOBEHarmony Biosciences Reports Strong Third Quarter 2023..
26/10/202307:05PRNUSHARMONY BIOSCIENCES SHOWCASES THE NEWEST PATIENTS AT THE..
17/10/202307:05PRNUSHARMONY BIOSCIENCES TO REPORT THIRD QUARTER 2023 FINANCIAL..
13/10/202307:15EDGAR2Form 8-K - Current report
13/10/202307:00PRNUSHARMONY BIOSCIENCES ANNOUNCES TOPLINE DATA FROM PHASE 3..
11/10/202307:15EDGAR2Form 8-K - Current report
11/10/202307:00PRNUSHARMONY BIOSCIENCES COMPLETES ACQUISITION OF ZYNERBA..
05/10/202315:15EDGAR2Form 8-K - Current report
05/10/202307:05PRNUSHARMONY BIOSCIENCES PRESENTS NEW SECONDARY OUTCOME DATA FROM..
04/10/202307:00EDGAR2Form 8-K - Current report
27/9/202307:00PRNUSHARMONY BIOSCIENCES ANNOUNCES EXTENSION OF TENDER OFFER TO..
25/9/202307:00EDGAR2Form 8-K - Current report
20/9/202307:05PRNUSHARMONY BIOSCIENCES PRESIDENT & CEO JEFFREY M. DAYNO, M.D.,..

Su Consulta Reciente

NASDAQ
HRMY
Harmony Biosciences
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados